Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
---|
09/07/2003 | CA2412065A1 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus |
09/04/2003 | WO2003072589A1 Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these |
09/04/2003 | WO2003072588A1 Macrolides with antibacterial activity |
09/04/2003 | WO2003072121A1 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient |
09/04/2003 | WO2002079465A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
09/04/2003 | CA2477555A1 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient |
09/03/2003 | EP1339731A1 Synthesis and separation of optically active isomers of erythromycin and their biological actions |
09/03/2003 | EP1339730A2 Macrolide solvates |
09/03/2003 | CN1120163C Soybean isoflavone and its prepn process with macroporous adsorption resin |
09/02/2003 | US6613889 Methylation of macrolide compound selected from amphotericin B, nystatin, pimaricin, amphotericin A, rimocidin, partricin, and anhydrous dimethylformamide by reacting with analdehyde and adding cesium carbonate and methyl iodide; acid treatment |
09/02/2003 | US6613747 6-O-carbamoyl ketolide antibacterials |
08/28/2003 | WO2003070908A2 Novel spinosyn-producing polyketide synthases |
08/28/2003 | WO2003070254A1 Antibiotic conjugates |
08/28/2003 | US20030162730 Crystal forms of azithromycin |
08/28/2003 | US20030162729 Such as derivatives of dodecahydro-14,1-(epiazenoethano) oxacyclotetradecin(4,3-d)1,3)oxazol-10-yl-3,4,6-trideoxy-3-(dimethylamino) -beta-D-xylo-hexopyranoside for treating infections in fish |
08/28/2003 | US20030162728 Process for preparing flavonoids |
08/28/2003 | US20030162262 A recombinant host cell, which in its untransformed state does not produce narbonolide, that consists of a recombinant DNA expression vector that encodes a narbonolide (polyketide synthase) PKS and produces narbonolide |
08/28/2003 | US20030162240 Contacting a chromogenic sialidase substrate with a substitued phenoxoypyran derivative and detecting a visible color change that indicates the presence of a sialidase |
08/28/2003 | US20030161900 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment |
08/28/2003 | CA2476448A1 Antibiotic conjugates |
08/27/2003 | EP1338603A1 Novel pyrazole derivatives and diabetes remedies containing the same |
08/27/2003 | EP1338270A2 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic composition |
08/27/2003 | EP1337540A2 Motilide compounds |
08/27/2003 | EP1011687A4 13-deoxyanthracycline derivatives and processes for preparing them |
08/27/2003 | CN1437953A Gentiamarin powder infection for muscle injection and intravenous injection |
08/27/2003 | CN1119144C Composition for external application of skin |
08/26/2003 | US6610299 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers. |
08/21/2003 | WO2003068793A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate |
08/21/2003 | WO2003068792A1 Process for producing erythromycin a derivative |
08/21/2003 | WO2003068791A2 Macrolides with activity against methicillin-resistant staphylococcus aureus |
08/21/2003 | WO2003068790A2 Macrolide antibacterial compounds |
08/21/2003 | WO2003068171A2 Method and composition for treatment of inflammation and aids-associated neurological disorders |
08/21/2003 | US20030158377 Forming libraries; immunosuppressant, antitumor agents |
08/21/2003 | CA2476223A1 Macrolide antibacterial compounds |
08/21/2003 | CA2472603A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate |
08/20/2003 | CN1437609A Method used for transforming the carbonyl function in position 4´“éof a cladinose unit of an aza macrolide into an amine derivative |
08/20/2003 | CN1436786A Extraction process of mangosteen glycoside from mangosteen |
08/20/2003 | CN1436785A Macroporous adsorbing resin process of extracting general flavone from haw leaf |
08/20/2003 | CN1436784A Extractant, extraction process and analysis method of high-activity ginkgo leaf extractive |
08/20/2003 | CN1436562A Hypericum perforatum extract and its prepn process and medicine composition |
08/19/2003 | US6608033 Treatment or prevention of coccidiosis |
08/19/2003 | US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
08/14/2003 | WO2003066059A1 Treatment of neuroblastoma |
08/14/2003 | WO2003066009A1 Topical ivermectin composition |
08/14/2003 | US20030153544 Fatty acid derivatives |
08/14/2003 | US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue |
08/13/2003 | EP1334726A1 Erythromycin derivative having novel crystal structures and processes for their production |
08/13/2003 | EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
08/13/2003 | EP1333826A2 Phase transfer catalyzed glycosidation of an indolocarbazole |
08/13/2003 | EP1333807A2 Extended release erythromycin derivatives |
08/13/2003 | CN1435424A High content ginkgo extract and process for producing same |
08/13/2003 | CN1117741C Heterocyclic fungicides |
08/12/2003 | US6605707 Process for the preparation of 6-O-propargyl erythromycin derivatives |
08/12/2003 | US6605595 Higher antiparasitic activity |
08/12/2003 | US6605299 Releasable linkage and compositions containing same |
08/07/2003 | WO2003064439A2 Sialic carbohydrates |
08/07/2003 | WO2003048375B1 Hybrid glycosylated products and their production and use |
08/07/2003 | US20030148964 Single dose azithromycin |
08/07/2003 | US20030148469 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
08/06/2003 | CN1434829A Processes for preparing clarithromycin polymorphs and novel polymorph IV |
08/06/2003 | CN1434053A Rhizoma anemarrhenae extract and preparation process and use thereof |
08/06/2003 | CN1434052A Cranesbill total flavonoid extract and use in preparation of anti-virus medicine |
08/06/2003 | CN1434042A Cattail pollen extract and preparation process and use thereof |
07/31/2003 | WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
07/31/2003 | WO2003061671A1 Amido macrolides |
07/31/2003 | CA2471383A1 Amido macrolides |
07/31/2003 | CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
07/30/2003 | EP0922050B1 3-descladinose-2,3-anhydroerythromycin derivatives |
07/30/2003 | EP0697814B1 Pour-on formulations containinng polymeric material, glycols and glycerides |
07/30/2003 | CN1432575A Tylan purifying process |
07/29/2003 | US6600025 Intermediates, process for preparing macrolide antibiotic agent therefrom |
07/29/2003 | US6599919 Administering reversible competitive inhibitor of enzyme in an amount effective to enhance activity of enzyme in cell |
07/29/2003 | US6599886 Macrolide intermediates in the preparation of clarithromycin |
07/29/2003 | US6599885 Adduct of antibiotic and mucolytic agent |
07/29/2003 | US6599884 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
07/29/2003 | CA2268437C Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |
07/24/2003 | WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
07/24/2003 | US20030139610 Washing the aqueous plant extract with a solvent, adjusting the pH from 10 to less 9, solvent extration of flavonoids |
07/24/2003 | US20030139583 Process for preparation of anhydrous azithromycin |
07/24/2003 | US20030138841 Library of novel ''unnatural'' natural products |
07/23/2003 | EP1328535A1 Macrolides |
07/23/2003 | EP1328534A2 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
07/23/2003 | EP1328236A2 Methods of decreasing or preventing pain using spicamycin derivatives |
07/23/2003 | EP1067969B1 Polyene macrolide derivatives, use for vectoring molecules |
07/23/2003 | CN1431216A Method for extracting naringin |
07/22/2003 | US6596761 Cosmetic and dermatological preparation with flavonoids |
07/22/2003 | US6596751 α-substituted carboxylic acid derivatives |
07/22/2003 | US6596696 Alpha-amylase inhibitor for the prophylaxis and treatment of hyperglycemia |
07/17/2003 | WO2003057707A1 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
07/17/2003 | US20030135108 High throughput screening methods using magnetic resonance imaging agents |
07/16/2003 | EP1326599A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
07/16/2003 | EP0830137B1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
07/15/2003 | US6593360 The invention relates to novel 15-membered 8a- and 9a-lactams from the class of 6-O-methyl-erythromycin A of general formula their pharmaceutically acceptable addition salts with inorganic or organic acids and their hydrates, to |
07/15/2003 | US6593302 Macrolide antiinfective agents |
07/10/2003 | WO2002048331A3 Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and 'unnatural' udp- and nucleotide sugars |
07/10/2003 | US20030130205 Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use |
07/10/2003 | US20030129263 Recovery of isoflavones from soy molasses |
07/09/2003 | EP1325748A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
07/09/2003 | CN1429233A Method of preparing clarithromycin of form II crystals |
07/09/2003 | CN1429232A Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals |